ErbB2:EGFR ratio is a critical predictor of a mitogenic response to EGF in a prostate cancer model - potential implications for the use of anti-ErbB2 or dual tyrosine kinase inhibitors

SS El-Sheikh, J Domin, P Abel, G Stamp, El-Nasir Lalani

    Research output: Contribution to journalArticle

    73 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)846-853
    Number of pages8
    Publication statusPublished - 1 Nov 2004

    Cite this